Trial Profile
A Randomized, Double-blinded, Multicenter, Placebo Controlled, Parallel Designed Study, to Evaluate the Efficacy and Safety of Tolvaptan Tablet in Treatment of Patients With Cirrhosis Ascites, Using Diuretics as Initial Treatment
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2021
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 23 Apr 2014 New trial record